WuXi AppTec Co., Ltd. (2359.HK)
2359.HK Stock Price Chart
Explore WuXi AppTec Co., Ltd. interactive price chart. Choose custom timeframes to analyze 2359.HK price movements and trends.
2359.HK Company Profile
Discover essential business fundamentals and corporate details for WuXi AppTec Co., Ltd. (2359.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
13 Dec 2018
Employees
39.41K
Website
https://www.wuxiapptec.comCEO
Ge Li
Description
WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.
2359.HK Financial Timeline
Browse a chronological timeline of WuXi AppTec Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 16 Mar 2026
Upcoming earnings on 16 Mar 2026
Upcoming earnings on 27 Oct 2025
Revenue estimate is $11.55B.
Dividend declared on 8 Sept 2025
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend will be paid on 26 Sept 2025.
Earnings released on 28 Jul 2025
EPS came in at $1.86 surpassing the estimated $1.48 by +25.68%, while revenue for the quarter reached $12.19B , beating expectations by +5.72%.
Earnings released on 28 Apr 2025
EPS came in at $1.36 surpassing the estimated $0.72 by +87.85%, while revenue for the quarter reached $10.30B , beating expectations by +1.04%.
Earnings released on 17 Mar 2025
EPS came in at $1.09 falling short of the estimated $1.38 by -21.01%, while revenue for the quarter reached $12.28B , beating expectations by +31.84%.
Earnings released on 28 Oct 2024
EPS came in at $0.79 falling short of the estimated $0.90 by -12.22%, while revenue for the quarter reached $11.58B , missing expectations by -7.15%.
Earnings released on 29 Jul 2024
EPS came in at $0.79 falling short of the estimated $0.82 by -3.66%, while revenue for the quarter reached $9.94B , beating expectations by +0.73%.
Dividend declared on 17 Jun 2024
A dividend of $1.09 per share was announced, adjusted to $1.09. The dividend was paid on 5 Jul 2024.
Earnings released on 30 Apr 2024
EPS came in at $0.66 falling short of the estimated $0.74 by -10.81%, while revenue for the quarter reached $8.64B , missing expectations by -5.29%.
Earnings released on 19 Mar 2024
EPS came in at $0.88 surpassing the estimated $0.54 by +62.96%, while revenue for the quarter reached $11.95B , beating expectations by +0.26%.
Earnings released on 31 Oct 2023
EPS came in at $0.94 surpassing the estimated $0.91 by +3.30%, while revenue for the quarter reached $11.44B , missing expectations by -5.41%.
Earnings released on 30 Jun 2023
EPS came in at $1.16 surpassing the estimated $0.93 by +24.87%, while revenue for the quarter reached $10.71B , missing expectations by -0.42%.
Dividend declared on 5 Jun 2023
A dividend of $0.99 per share was announced, adjusted to $0.99. The dividend was paid on 27 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at $0.82 falling short of the estimated $0.87 by -5.52%, while revenue for the quarter reached $10.23B , missing expectations by -11.51%.
Earnings released on 23 Mar 2023
EPS came in at $0.52 falling short of the estimated $0.78 by -33.33%, while revenue for the quarter reached $12.48B , beating expectations by +1.92%.
Earnings released on 30 Sept 2022
EPS came in at $0.97 surpassing the estimated $0.75 by +29.08%, while revenue for the quarter reached $11.69B , missing expectations by -3.51%.
Earnings released on 30 Jun 2022
EPS came in at $1.13 surpassing the estimated $0.86 by +31.09%, while revenue for the quarter reached $10.87B , beating expectations by +9.53%.
Dividend declared on 30 May 2022
A dividend of $0.62 per share was announced, adjusted to $0.62. The dividend was paid on 17 Jun 2022.
Earnings released on 31 Mar 2022
EPS came in at $0.65 surpassing the estimated $0.59 by +11.24%, while revenue for the quarter reached $10.44B , beating expectations by +0.13%.
Earnings released on 15 Feb 2022
EPS came in at $0.52 surpassing the estimated $0.34 by +52.94%, while revenue for the quarter reached $7.81B , beating expectations by +2.41%.
Earnings released on 30 Oct 2021
EPS came in at $0.30 falling short of the estimated $0.33 by -9.09%, while revenue for the quarter reached $7.22B .
Earnings released on 13 Aug 2021
EPS came in at $0.40 surpassing the estimated $0.10 by +300.00%, while revenue for the quarter reached $6.71B .
Dividend declared on 28 May 2021
A dividend of $0.36 per share was announced, adjusted to $0.37. The dividend was paid on 17 Jun 2021.
Stock split effective on 28 May 2021
Shares were split 6 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Apr 2021
EPS came in at $0.51 surpassing the estimated $0.18 by +183.33%, while revenue for the quarter reached $5.86B .
Earnings released on 8 Mar 2021
EPS came in at $0.21 falling short of the estimated $0.30 by -30.00%, while revenue for the quarter reached $5.61B .
Earnings released on 29 Oct 2020
EPS came in at $0.23 falling short of the estimated $0.28 by -17.86%, while revenue for the quarter reached $5.23B .
2359.HK Stock Performance
Access detailed 2359.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.